Although Colorado voters approved a groundbreaking psychedelics legalization ballot measure in 2022, it’s still being implemented by lawmakers, who introduced yet another bill introduced at the state capitol to set the stage for a medical psilocybin industry. However, the legislative session will adjourn in a month, which doesn’t leave much …
Canadian psychedelics company Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) inked a deal to supply a New Zealand research institute with psilocybin, giving the company a boost to its international dealings. Although Optimi already has a psychedelic footprint in neighboring Australia, the new supply deal – with the …
Vancouver-based AgriCann Solutions Corp. issued a letter to its shareholders saying it would shut down cultivation operations for three months as the company goes through major changes. Chairman Rob van Santen, to whom the letter was attributed, blamed the company’s growth attempts in 2023, which burned through cash as it …
Biopharmaceutical company Synaptogenix, Inc. (Nasdaq: SNPX) has increased its stake in the psilocybin drug discovery company PsygaBio through its previously announced partnership with Cannasoul Analytics. Synaptogenix had taken a 25% stake in Cannasoul in November of 2023 to support research and development for psilocybin mushroom and cannabinoid-based therapeutics. The company …